Kamada Ltd. announced it will release financial results for the fourth quarter and fiscal year ended December 31, 2025, prior to the U.S. market open on March 11, 2026, and host a conference call at 8:30am ET to discuss these results. This provides investors with upcoming access to detailed financial performance data and management commentary.
Key takeaways
Financial results release for Q4 and FY 2025 on March 11, 2026, before U.S. market open
Conference call on March 11, 2026, at 8:30am ET with conference ID 13758519
U.S. dial-in: 1-877-407-0792; Israel: 1-809-406-247; International: 1-201-689-8263
Live webcast at https://viavid.webcasts.com/starthere.jsp?ei=1751343&tp_key=e8c73d1516
FIMI Opportunity Funds owns approximately 38% of outstanding ordinary shares
Company operates three plasma collection centers in Beaumont, Houston, and San Antonio, Texas